FDA.reportPublic FDA data

loteprednol etabonate 1 % Ophthalmic Suspension

RxCUI
2055281
RxNorm name
loteprednol etabonate 1 % Ophthalmic Suspension
Display name
loteprednol etabonate 1 % Ophthalmic Suspension
Full name
loteprednol etabonate 1 % Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2ec16df8-2e5c-4e06-8d28-21df76f27d72loteprednol etabonate 1 % Ophthalmic Suspension [PSN] · loteprednol etabonate 10 MG/ML Ophthalmic Suspension [SCD] · loteprednol etabonate 1 % Ophthalmic Suspension [SY]310These highlights do not include all the information needed to use INVELTYS ® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820240327
bdd18e84-79b3-4c8b-a07f-eb06cf52e68cloteprednol etabonate 1 % Ophthalmic Suspension [PSN] · loteprednol etabonate 10 MG/ML Ophthalmic Suspension [SCD] · loteprednol etabonate 1 % Ophthalmic Suspension [SY]31These highlights do not include all the information needed to use INVELTYS® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval 199820260427